December 2023 Publications
- Non-clinical evaluation of local and systemic immunity induced by different vaccination strategies of the candidate tuberculosis vaccine M72/AS01. Ouaked N, Demoitié MA, Godfroid F, Mortier MC, Vanloubbeeck Y, Temmerman ST. Tuberculosis (Edinb). 2023 Dec. doi: 10.1016/j.tube.2023.102425.
- Antibody reactivity to Mycobacterium tuberculosis-specific regions of differences 1 and regions of differences 9 proteins and peptides in rabbits, mice, and humans. M Hanif SN, Al-Attiyah R, Mustafa AS. Int J Mycobacteriol. 2023 Oct-Dec. doi: 10.4103/ijmy.ijmy_157_23
- The interaction of macrophages and CD8 T cells in bronchoalveolar lavage fluid is associated with latent tuberculosis infection. Yang Q, Qi F, Ye T, Li J, Xu G, He X, Deng G, Zhang P, Liao M, Qiao K, Zhang Z. Emerg Microbes Infect. 2023 Dec. doi: 10.1080/22221751.2023.2239940.
- The functions and applications of extracellular vesicles derived from Mycobacterium tuberculosis. Li Y, Qian Y, Wang N, Qiu D, Cao H, Wang Y, Luo H, Shen X, Cui H, Wang J, Zhu H. Biomed Pharmacother. 2023 Dec. doi: 10.1016/j.biopha.2023.115767.
- CD8+ lymphocytes are critical for early control of tuberculosis in macaques. Winchell CG, Nyquist SK, Chao MC, Maiello P, Myers AJ, Hopkins F, Chase M, Gideon HP, Patel KV, Bromley JD, Simonson AW, Floyd-O’Sullivan R, Wadsworth M, Rosenberg JM, Uddin R, Hughes T, Kelly RJ, Griffo J, Tomko J, Klein E, Berger B, Scanga CA, Mattila J, Fortune SM, Shalek AK, Lin PL, Flynn JL. J Exp Med. 2023 Dec 4. doi: 10.1084/jem.20230707. Epub 2023 Oct 16.
- Immunogenicity of PE18, PE31, and PPE26 proteins from Mycobacterium tuberculosis in humans and mice. García-Bengoa M, Vergara EJ, Tran AC, Bossi L, Cooper AM, Pearl JE, Mussá T, von Köckritz-Blickwede M, Singh M, Reljic R. Front Immunol. 2023 Dec 6. doi: 10.3389/fimmu.2023.1307429.
- Vaccine development: Current trends and technologies. Poria R, Kala D, Nagraik R, Dhir Y, Dhir S, Singh B, Kaushik NK, Noorani MS, Kaushal A, Gupta S. Life Sci. 2023 Dec 7. doi: 10.1016/j.lfs.2023.122331.
- Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity. Vergara EJ, Tran AC, Kim MY, Mussá T, Paul MJ, Harrison T, Reljic R. Front Immunol. 2023 Dec 7. doi: 10.3389/fimmu.2023.1306449.
- Mucosal and systemic antigen-specific antibody responses correlate with protection against active tuberculosis in nonhuman primates. Ishida E, Corrigan DT, Chen T, Liu Y, Kim RS, Song L, Rutledge TM, Magee DM, LaBaer J, Lowary TL, Lin PL, Achkar JM. EBioMedicine. 2023 Dec 13. doi: 10.1016/j.ebiom.2023.104897. Epub ahead of print.
- Research progress in the off-target effects of Bacille Calmette-Guérin vaccine. Wu Y, Zhang X, Zhou L, Lu J, Zhu F, Li J. Chin Med J (Engl). Published online December 13, 2023. doi:10.1097/CM9.0000000000002890.
- A potent subset of Mycobacterium tuberculosis glycoproteins as relevant candidates for vaccine and therapeutic target. Yari S, Afrough P, Yari F, Ghazanfari Jajin M, Fateh A, Hadizadeh Tasbiti A. Sci Rep. 2023 Dec 14. doi: 10.1038/s41598-023-49665-2.
- Antibodies as clinical tools for tuberculosis. McIntyre S, Warner J, Rush C, Vanderven HA. Front Immunol. 2023 Dec 14. doi: 10.3389/fimmu.2023.1278947.
- Safety and Immunogenicity of an In Vivo Muscle Electroporation Delivery System for DNA-hsp65 Tuberculosis Vaccine in Cynomolgus Monkeys. de Lima MR, Leandro ACCS, de Souza AL, Barradas MM, Roma EH, Fernandes ATG, Galdino-Silva G, Carvalho JKMR, Marchevsky RS, Coelho JMCO, Gonçalves EDC, VandeBerg JL, Silva CL, Bonecini-Almeida MDG. Vaccines (Basel). 2023 Dec 18. doi: 10.3390/vaccines11121863.
- A secreted form of chorismate mutase (Rv1885c) in Mycobacterium bovis BCG contributes to pathogenesis by inhibiting mitochondria-mediated apoptotic cell death of macrophages. Lee MH, Kim HL, Seo H, Jung S, Kim BJ. J Biomed Sci. 2023. Published 2023 Dec 18. doi:10.1186/s12929-023-00988-2.
- Distinct gene expression signatures comparing latent tuberculosis infection with different routes of Bacillus Calmette-Guérin vaccination. Silver RF, Xia M, Storer CE, Jarvela JR, Moyer MC, Blazevic A, Stoeckel DA, Rakey EK, Tennant JM, Goll JB, Head RD, Hoft DF. Nat Commun. 2023 Dec 21. doi: 10.1038/s41467-023-44136-8.
- Double BCG vaccination in a neonate: implications, management and prevention. Chetan C, Patra S, Singh SK, Gupta G. BMJ Case Rep. 2023. Published 2023 Dec 28. doi:10.1136/bcr-2023-256766.
- Exploring the ethics of tuberculosis human challenge models. Rohrig A, Morrison J, Kleinwaks G, Pugh J, McShane H, Savulescu J. J Med Ethics. 2023 Dec 30. doi: 10.1136/jme-2023-109234.
- Efficacy of light chain 3-fused protein multi epitope in protection of mice challenged with Mycobacterium tuberculosis. Bahrami S, Feizabadi MM, Mosavari N, Sotoodehnejad F, Eslampanah M. Vet Res Forum. 2023. doi:10.30466/vrf.2023.1975747.3702.
- Saponin TQL1055 adjuvant-containing vaccine confers protection upon Mycobacterium tuberculosis challenge in mice. Ahmed M, Farris E, Swanson RV, Das S, Yang Y, Martin T, Khader SA. Hum Vaccin Immunother. 2023 Dec 31. doi: 10.1080/21645515.2024.2302070.
- Assessment of adherence to pre-vaccination precautions and AEFI reporting practices during BCG vaccination in 4 hospitals in Ghana. Yamoah P, Mensah KB, Padayachee N, Bangalee V, Oosthuizen F. Hum Vaccin Immunother. 2023 Dec 31. doi: 10.1080/21645515.2023.2199654.